Dr. Neil Kay on Prognostic Indicators and Standard Early Care for Chronic Lymphocytic Leukemia: Dr. Neil Kay, a fellow Canadian, of the Mayo Clinic has been a leader in CLL research for decades including foundational work on clonal heterogeneity and evolution, prognostic indicators and algorithms, Monoclonal B-cell lymphocytosis (MBL)
September 29, 2022
BREAKING NEWS
Smart Patients Get Smart Care™
The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients
Menu
